Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-024869
Filing Date
2013-05-02
Accepted
2013-05-02 20:45:51
Documents
1
Period of Report
2013-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd378059.html 4  
1 FORM 4 rrd378059.xml 4 3778
  Complete submission text file 0001181431-13-024869.txt   5152
Mailing Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Issuer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address KALOBIOS PHARMACEUTICALS, INC. 260 EAST GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address
Pritchard David (Reporting) CIK: 0001555791 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35798 | Film No.: 13809933